TY PHAR.: Abnormal fluctuations in stock trading

TY PHAR. announced that the closing price of the company's stock has increased by more than 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. After verification, the company's operations are normal, and there have been no significant changes in the disclosed operating conditions and internal and external environments. The previously disclosed information does not need to be corrected or supplemented. The company has not found any undisclosed significant information in recent public media reports that may affect the stock price, and there have been no transactions involving the company's stock by the controlling shareholder and actual controller during the period of abnormal fluctuation